"At Mosaic Life Care, we are committed to providing the best and safest care, while creating a warm, inviting environment for our patients, family members and caregivers. Our innovative life-care model combines traditional health care and a focus on key life elements that affect overall wellness. It is our commitment to the health, well-being and vitality of the communities and organizations we serve through health-related initiatives and opportunities."

During the past decade, St. Joseph Oncology, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Joseph Oncology, Inc." #1 sponsor was "US Oncology Research" with 4 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Point Therapeutics" with 2 trials sponsored, "Agennix" with 1 trials sponsored and "Celgene Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Joseph Oncology, Inc." #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator, "Medarex" with 1 trials as a collaborator and "Oregon Health and Science University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "St. Joseph Oncology, Inc." are "Melanoma" (3 trials), "Prostate Cancer" (2 trials), "Androgen-independent Prostate Cancer" (1 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials) and "Carcinoma, Non-Small Cell Lung" (1 trials). Many other conditions were trialed in "St. Joseph Oncology, Inc." in a lesser frequency.

Most popular intervention types in "St. Joseph Oncology, Inc." are "Drug" (13 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (2 trials), "docetaxel" (2 trials), "5-fluorouracil" (1 trials), "Amrubicin" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Joseph Oncology, Inc." are 10 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "St. Joseph Oncology, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in St. Joseph Oncology, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. Joseph Oncology, Inc., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".